China National Medicines Corp Ltd
SSE:600511
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
First Tractor Co Ltd
SSE:601038
|
CN |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
JP |
|
N
|
National United Resources Holdings Ltd
HKEX:254
|
HK |
|
Tbea Co Ltd
SSE:600089
|
CN |
|
U
|
Universal Global Hub Inc
OTC:UGHB
|
US |
|
Lite-On Technology Corp
TWSE:2301
|
TW |
|
M
|
MedNation AG
SWB:EIF
|
DE |
|
FM Mattsson AB (publ)
STO:FMM B
|
SE |
|
B
|
Benefit Japan Co Ltd
TSE:3934
|
JP |
|
V
|
VRL Logistics Ltd
BSE:539118
|
IN |
|
I
|
Isata Ltd
TASE:ISTA
|
IL |
|
H
|
Hongli Group Inc
NASDAQ:HLP
|
CN |
|
Squarespace Inc
NYSE:SQSP
|
US |
|
Tiger Logistics (India) Ltd
BSE:536264
|
IN |
|
G
|
G Mining Ventures Corp
XTSX:GMIN
|
CA |
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
CN |
|
L
|
Luharuka Media & Infra Ltd
BSE:512048
|
IN |
China National Medicines Corp Ltd
Research & Development
China National Medicines Corp Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Research & Development
-¥73.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Research & Development
-¥2.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Research & Development
-¥146.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Research & Development
-¥2B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Research & Development
-¥21.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
China National Medicines Corp Ltd
Glance View
China National Medicines Corp Ltd., often known as Sinopharm Group's public face, is a leviathan in the realm of pharmaceutical distribution. Headquartered in Beijing, this company is deeply entrenched in the layers of China's healthcare system. Its operations are woven through a vast network that includes the wholesale and retail distribution of an extensive range of pharmaceutical products. The company prides itself on streamlining the supply chain, connecting pharmaceutical manufacturers directly with hospitals, clinics, and pharmacies. By leveraging its logistical expertise and expansive reach, Sinopharm ensures that essential medicines flow seamlessly from producers to end-users, maintaining the vital heartbeat of the healthcare industry across China. In addition to its core distribution business, China National Medicines Corp Ltd. delves into the realm of medical device distribution and other healthcare-related services, diversifying its revenue streams. A significant portion of its income comes from partnerships and agreements with international pharmaceutical behemoths, allowing it to import and distribute advanced medicines and technology within China. By capitalizing on these strategic alliances, the company not only bolsters its portfolio but also strengthens its market position. This symbiotic relationship with both domestic and global players underpins its financial performance, making China National Medicines not just a distributor but a pivotal gatekeeper in the evolving landscape of China's healthcare industry.
See Also
What is China National Medicines Corp Ltd's Research & Development?
Research & Development
-73.2m
CNY
Based on the financial report for Sep 30, 2025, China National Medicines Corp Ltd's Research & Development amounts to -73.2m CNY.
What is China National Medicines Corp Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-3%
Over the last year, the Research & Development growth was -18%. The average annual Research & Development growth rates for China National Medicines Corp Ltd have been -7% over the past three years , -3% over the past five years .